Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid

BioTechGrid

  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
Posted inBiotechnology

Spermine: Natural Iron Chelator Prevents Ferroptosis

June 3, 2026
Continue Reading
spermine:-natural-iron-chelator-prevents-ferroptosis
Posted inBiotechnology

Barriers to Rapid Fever Test Use in Africa

June 3, 2026
Continue Reading
barriers-to-rapid-fever-test-use-in-africa
Posted inBiotechnology

Acridine Compound Binds VEGF, Cuts CAM Vascularization

June 3, 2026
Continue Reading
acridine-compound-binds-vegf,-cuts-cam-vascularization
Posted inBiotechnology

Geriatric Assessments Boost Outcomes, Cut Costs in Thailand

June 3, 2026
Continue Reading
geriatric-assessments-boost-outcomes,-cut-costs-in-thailand
Posted inBiotechnology

On-Demand Nanomanufacturing of Electronics in Microgravity

June 3, 2026
Continue Reading
on-demand-nanomanufacturing-of-electronics-in-microgravity
Posted inBiotechnology

Even “Safe” Air Pollution Levels Pose Health Risks

June 3, 2026
Continue Reading
even-“safe”-air-pollution-levels-pose-health-risks
Most Popular Post
exploring-the-future-of-healthcare with-panos-karelis
Posted inArtificial intelligence

Exploring the Future of Healthcare with Panos Karelis

exploring-the-future-of-healthcare with-gordon-wishart,-check4cancer
Posted inArtificial intelligence

Exploring the Future of Healthcare with Gordon Wishart, Check4Cancer

exploring-the-future-of-healthcare with-noam-shomron,-tel-aviv-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Noam Shomron, Tel Aviv University

exploring-the-future-of-healthcare with-raul-villamarin-rodriguez,-woxsen-university
Posted inArtificial intelligence

Exploring the Future of Healthcare with Raul Villamarin Rodriguez, Woxsen University

sanofi,-teva-look-to-‘next-frontier’-in-ibd-treatment-after-tl1a-antibody-hits-mark-in-midstage-trial
Posted inBiotechnology

Sanofi, Teva look to ‘next frontier’ in IBD treatment after TL1A antibody hits mark in midstage trial

December 17, 2024
As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and Teva…
Read More
biomea’s-diabetes-drug-improves-glucose-control-3-months-after-fda-hold-lifted
Posted inBiotechnology

Biomea’s diabetes drug improves glucose control 3 months after FDA hold lifted

December 17, 2024
Three months after Biomea Fusion’s menin inhibitor was released from a clinical hold, the company has claimed a win in…
Read More
cash-strapped-portage-finds-hope-in-sale-of-lead-asset,-subsidiary-to-immunova
Posted inBiotechnology

Cash-strapped Portage finds hope in sale of lead asset, subsidiary to Immunova

December 17, 2024
After spending most of the year hunting for options to stay afloat, cash-strapped Portage Biotech appears to have found salvation…
Read More
fresh-off-$120m-raise,-ai-powered-terray-is-teaming-up-with-gilead-in-multi-pronged-r&d-pact
Posted inBiotechnology

Fresh off $120M raise, AI-powered Terray is teaming up with Gilead in multi-pronged R&D pact

December 17, 2024
Terray is ending the year on a high. Just two short months ago the biotech came out with a healthy…
Read More
fierce-biotech’s-top-10-editor’s-picks-for-2024
Posted inBiotechnology

Fierce Biotech’s top 10 editor’s picks for 2024

December 17, 2024
The year kicked off with a flurry of dealmaking at the J.P. Morgan Healthcare Conference in January, and the pace…
Read More
merck-drops-tigit-asset-and-lag-3-program,-discontinuing-several-phase-3-trials
Posted inBiotechnology

Merck drops TIGIT asset and LAG-3 program, discontinuing several phase 3 trials

December 16, 2024
Out with the old, in with the new. The end of the year in biopharma is typically marked by pipeline…
Read More
american-society-of-hematology-member-surveys-identify-barriers-to-improving-diversity-in-clinical-trials
Posted inResearch

American Society of Hematology member surveys identify barriers to improving diversity in clinical trials

December 16, 2024
A pair of assessments conducted by the American Society of Hematology (ASH) have helped identify roadblocks to improving diversity in…
Read More
boston-scientific-recalls-pacemakers-at-risk-of-triggering-permanent-safety-mode
Posted inMedical Technology

Boston Scientific recalls pacemakers at risk of triggering permanent safety mode

December 16, 2024
The FDA is boosting a recall effort from Boston Scientific regarding batteries potentially underpowering a number of the company’s implanted…
Read More
ucb’s-orchestra-hits-dud-note:-novartis-partnered-parkinson’s-asset-fails-phase-2
Posted inBiotechnology

UCB’s orchestra hits dud note: Novartis-partnered Parkinson’s asset fails phase 2

December 16, 2024
UCB’s Novartis-partnered investigational small molecule has failed to improve symptoms of Parkinson’s disease in a phase 2a trial. The oral…
Read More
roche-mothballs-another-hemophilia-a-gene-therapy-under-spark-amid-plans-to-debut-new-hematologic-asset
Posted inBiotechnology

Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset

December 16, 2024
Following the apparent elimination of a late-stage gene therapy study last week, Swiss drug juggernaut Roche has confirmed that it’s…
Read More

Posts pagination

Previous page 1 … 1,906 1,907 1,908 1,909 1,910 … 1,916 Next page
You May Have Missed
imu-biosciences-nabs-$53m-funding-round-to-‘decode’-the-immune-system
Posted inMedical Technology

IMU Biosciences nabs $53M funding round to ‘decode’ the immune system

foundation-medicine-tallies-fda-nod-to-pair-its-blood-test-with-pfizer’s-prostate-cancer-combo
Posted inMedical Technology

Foundation Medicine tallies FDA nod to pair its blood test with Pfizer’s prostate cancer combo

mindmaze-therapeutics-culls-program,-ends-legacy-ops-from-relief-merger-to-cut-costs
Posted inMedical Technology

MindMaze Therapeutics culls program, ends legacy ops from Relief merger to cut costs

human-longevity-launches-newco,-teams-with-insilico-for-ai-powered-longevity-research
Posted inMedical Technology

Human Longevity launches newco, teams with Insilico for AI-powered longevity research

Privacy Policy    Terms

Scroll to Top